| Identification | Back Directory | [Name]
(1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester | [CAS]
361440-67-7 | [Synonyms]
SGB
EOS-60426
Saxagliptin int
Saxagliptin INT 2
N-Boc-cis-4,5-Methano-L-prolinamide
N-Boc-L-cis-4,5-MethanoprolineaMide
SAXAGLIPTIN CAS 3611442-04-8 INTERMEDIATES
(1S,3S,5S)-2-Boc-2-azabicyclo-[3.1.0]hexane-3-carboxamide
-tert-Butyl 3-carbamoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate
(1S,3S,5S)-2-(tert-butyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide
tert-butyl(1S,3S,5S)-3-carbamoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate
(1S,3S,5S)-3-(AMinocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid
(1S,3S,5S)-tert-butyl 3-carbaMoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate
ABHB (1S,3S,5S)-tert-butyl 3-carbamoyl-2-aza-bicyclo[3.1.0]hexane-2-carboxylate
(1S, 3S, 5S) -3- (amino-carbonyl) -2-azabicyclic [3.1.0] hexane-2-tert-butyl carboxylate
(1S,3S,5S)-3-(AMinocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl este
(1S,3S,5S)-3-(AMinocarbonyl)-2-azabicylo[3.1.0]hexane-2-carboxylic acid tert-butyl ester
(1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester
(1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acidd tert-butyl ester
(1S,3S,5S)-3-(AMINOCARBONYL)-2-AZABICYCLO[3.1.0]HEXANE-2-CARBOXYLIC ACID TERT-BUTYL ESTER1S
(1S,3S,5S)-3-Aminocarbonyl-2-Azabicyclo[3.1.0]Hexane-2-Carboxylicacid,1,1-Dimethylethyl Ester
2-Azabicyclo[3.1.0]hexane-2-carboxylic acid, 3-(aminocarbonyl)-, 1,1-dimethylethyl ester, (1S,3S,5S)-
(1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester(For export only)
(1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester ISO 9001：2015 REACH | [EINECS(EC#)]
1308068-626-2 | [Molecular Formula]
C11H18N2O3 | [MDL Number]
MFCD13151933 | [MOL File]
361440-67-7.mol | [Molecular Weight]
226.27 |
| Hazard Information | Back Directory | [Uses]
N-Boc-L-cis-4,5-Methanoprolineamide is an intermediate used to prepare methanoprolinenitrile-contg. dipeptide mimetics as DPP-IV inhibitors and as antidiabetic agents. |
|
|